OraSure Technologies Accounts Receivables 2011-2026 | OSUR

Accounts receivable — is the amount of money owed to a company by other organizations, individuals, or the government. It arises when a company has already delivered goods, performed work, or provided services, but has not yet received payment for them.

Examples of accounts receivable

Customers have not paid invoices for delivered products
An advance has been paid to a supplier, but goods have not yet been received
Employees have not reported on accountable amounts
The government must refund tax overpayments
Outstanding loans issued

Importance of accounts receivable in company analysis

Asset quality
Accounts receivable are part of current assets. But they are not cash — they are promises. Investors assess how realistic these promises are to be collected. The higher the share of overdue or doubtful receivables, the greater the risk of asset impairment.
Impact on cash flow
Even if a company shows a profit, the money can be "tied up" in receivables. This means profit does not turn into actual cash, and the company may face liquidity shortages.
Assessment of management efficiency
The following accounts receivable turnover ratios are commonly used:
Receivables turnover = Revenue / Average accounts receivable
(the higher — the better)

Days Sales Outstanding (DSO) = 365 / Turnover
(the fewer days — the faster customers pay)

If the DSO is constantly increasing — this is a red flag — customers are delaying payments, and money gets stuck in settlements.

Annual Accounts Receivables OraSure Technologies

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011	2010	2009	2008
22.2 M	23.8 M	40.2 M	70.8 M	45.3 M	38.8 M	36.9 M	34.8 M	42.5 M	19.8 M	19.3 M	16.1 M	13 M	17.5 M	17.2 M	12.5 M	-	-

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
70.8 M	12.5 M	29.4 M

Quarterly Accounts Receivables OraSure Technologies

2026-Q1	2025-Q3	2025-Q2	2025-Q1	2024-Q4	2024-Q3	2024-Q2	2024-Q1	2023-Q4	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
24.8 M	24.3 M	25.9 M	21.5 M	23.8 M	27 M	38.1 M	34 M	40.2 M	-	52.8 M	107 M	70.8 M	61.3 M	62.9 M	59.7 M	45.3 M	40.1 M	35.3 M	36.4 M	38.8 M	38.8 M	38.8 M	38.8 M	36.9 M	36.9 M	36.9 M	36.9 M	34.8 M	34.8 M	34.8 M	34.8 M	42.5 M	42.5 M	42.5 M	42.5 M	19.8 M	19.8 M	19.8 M	19.8 M	19.3 M	19.3 M	19.3 M	19.3 M	16.1 M	16.1 M	16.1 M	16.1 M	13 M	13 M	13 M	13 M	17.5 M	17.5 M	17.5 M	17.5 M	17.2 M	17.2 M	17.2 M	17.2 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
107 M	13 M	31.5 M

Accounts Receivables of other stocks in the Medical instruments industry

Issuer	Accounts Receivables	Price	% 24h	Market Cap	Country
Atrion Corporation ATRI	23 K	-	-	$ 810 M	USA
The Cooper Companies COO	829 M	$ 68.27	-0.52 %	$ 13.6 B	USA
Glaukos Corporation GKOS	109 M	$ 122.52	-3.02 %	$ 7.01 B	USA
Intuitive Surgical ISRG	1.53 B	$ 419.07	-1.77 %	$ 150 B	USA
ICU Medical ICUI	181 M	$ 142.57	0.4 %	$ 3.51 B	USA
iRhythm Technologies IRTC	75.7 M	$ 114.82	0.87 %	$ 3.67 B	USA
Repro Med Systems KRMD	6.21 M	$ 3.99	-0.25 %	$ 184 M	USA
LeMaitre Vascular LMAT	33.6 M	$ 95.84	-0.78 %	$ 2.17 B	USA
Masimo Corporation MASI	141 M	$ 179.95	-	$ 9.59 B	USA
Microbot Medical MBOT	159 K	$ 1.8	-1.1 %	$ 82.4 M	Israel
Ekso Bionics Holdings EKSO	7.31 M	-	-	$ 28.6 M	USA
Milestone Scientific MLSS	475 K	$ 0.39	1.99 %	$ 32 M	USA
Merit Medical Systems MMSI	204 M	$ 67.19	-0.47 %	$ 3.97 B	USA
electroCore ECOR	1.03 M	$ 9.41	-1.16 %	$ 79.8 K	USA
Envista Holdings Corporation NVST	430 M	$ 24.52	-0.28 %	$ 4.12 B	USA
Haemonetics Corporation HAE	217 M	$ 79.71	1.27 %	$ 3.76 B	USA
Isoray ISR	6 K	-	0.03 %	$ 108 M	USA
STERIS plc STE	1.09 B	$ 210.4	-1.16 %	$ 20.7 B	USA
STAAR Surgical Company STAA	50.1 M	$ 29.72	-0.52 %	$ 1.47 B	USA
InfuSystem Holdings INFU	22.9 M	$ 9.01	-0.22 %	$ 186 M	USA
Teleflex Incorporated TFX	346 M	$ 135.28	-0.35 %	$ 6.04 B	USA
West Pharmaceutical Services WST	574 M	$ 331.0	-1.09 %	$ 23.9 B	USA
Utah Medical Products UTMD	3.52 M	$ 68.56	0.72 %	$ 222 M	USA
Pulse Biosciences PLSE	274 K	$ 25.18	-2.31 %	$ 1.7 B	USA
Retractable Technologies RVP	7.9 M	$ 0.69	-0.16 %	$ 20.7 M	USA
Pro-Dex PDEX	16.4 M	$ 64.36	-0.99 %	$ 212 M	USA
Predictive Oncology POAI	32.1 K	-	-	$ 31.1 M	USA
BioLife Solutions BLFS	7.95 M	$ 27.48	-0.25 %	$ 1.31 B	USA
Stereotaxis STXS	5.85 M	$ 1.86	0.27 %	$ 169 M	USA
Baxter International BAX	1.7 B	$ 20.58	2.75 %	$ 10.6 B	USA
ResMed RMD	576 M	$ 196.49	-0.23 %	$ 28.7 B	USA
AtriCure ATRC	66.7 M	$ 27.31	0.02 %	$ 1.3 B	USA
Harvard Bioscience HBIO	16 M	$ 6.28	3.97 %	$ 279 M	USA
NeuroMetrix NURO	193 K	-	5.05 %	$ 9.02 M	USA
AngioDynamics ANGO	42.9 M	$ 12.39	0.36 %	$ 506 M	USA
Becton, Dickinson and Company BDX	2.99 B	$ 150.25	-1.18 %	$ 43.2 B	USA
Nephros NEPH	2.41 M	$ 3.24	-0.46 %	$ 34.4 M	USA
Repligen Corporation RGEN	159 M	$ 132.2	1.59 %	$ 7.43 M	USA